Venture Life Updates Share Capital and Voting Rights Total

Venture Life ( (GB:VLG) ) just unveiled an update.

Venture Life Group has reported that, as of 31 January 2026, it has 128,812,145 ordinary shares in issue, of which 4,372,800 are held in treasury, resulting in 124,439,345 voting rights. The updated voting rights figure provides the new denominator for shareholders assessing disclosure obligations under UK transparency rules, clarifying the company’s current capital structure and ensuring investors can accurately determine when to notify holdings or changes in their interests in Venture Life’s share capital.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £66.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group is a UK-headquartered international consumer self-care company focused on commercialising over-the-counter products for the global self-care market. Its portfolio includes brands such as Balance Activ in women’s intimate healthcare, Earol for ENT care, Lift and Glucogel for energy and glucose management and hypoglycaemia, and the Health & Her range supporting the hormonal lifecycle, sold through pharmacies, health and beauty retailers, grocery chains and e-commerce channels worldwide via both direct supply and distribution partners.

Average Trading Volume: 240,530

Technical Sentiment Signal: Buy

Current Market Cap: £82.75M

See more data about VLG stock on TipRanks’ Stock Analysis page.